Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-25

FDA Approved: ADAPALENE — Supplemental Application (Mayne Pharma Commercial LLC.)

View source ↗

Summary

FDA approves a supplemental application for adapalene from Mayne Pharma Commercial LLC., likely related to labeling updates for acne treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene (Adapalene)

Snippet

SUPPL AP for ADAPALENE (ADAPALENE)